BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15243022)

  • 1. Factor V Leiden mutation and pregnancy.
    Langan RC
    J Am Board Fam Pract; 2004; 17(4):306-8. PubMed ID: 15243022
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor V Leiden: a review of the literature.
    Ament L
    J Perinat Neonatal Nurs; 2003; 17(3):190-5. PubMed ID: 12959480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative anticoagulation with danaparoid in two pregnancies in a patient with former heparin-induced thrombocytopenia (HIT), homozygous factor V Leiden mutation, a history of venous thrombosis and recurrent pregnancy losses.
    Schindewolf M; Lindhoff-Last E
    Thromb Haemost; 2008 Apr; 99(4):776-8. PubMed ID: 18392337
    [No Abstract]   [Full Text] [Related]  

  • 4. Homozygous factor V Leiden mutation in a woman with multiple adverse pregnancy outcomes.
    Pauer HU; Neesen J; Schloesser M; Hinney B; Rauskolb R
    Arch Gynecol Obstet; 2000 Nov; 264(3):164-5. PubMed ID: 11129520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two successful pregnancies in a carrier of heterozygous factor V LEIDEN mutation with aplasia of the inferior vena cava and a history of proximal deep venous thrombosis.
    Hauck-Dlimi B; Zimmermann R; Eckstein R; Ringwald J
    Arch Gynecol Obstet; 2014 Jun; 289(6):1375-6. PubMed ID: 24563163
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V Leiden mutation.
    Younis JS; Ohel G; Brenner B; Haddad S; Lanir N; Ben-Ami M
    BJOG; 2000 Mar; 107(3):415-9. PubMed ID: 10740341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A low rate of factor V Leiden mutation among Sudanese women with deep venous thrombosis during pregnancy and puerperium.
    Awad-Elkareem A; Elzaki SG; Khalid H; Abdallah MS; Adam I
    J Obstet Gynaecol; 2017 Oct; 37(7):963-964. PubMed ID: 28395587
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of central neuraxial techniques in parturients with factor V leiden mutation.
    Harnett MJ; Walsh ME; McElrath TF; Tsen LC
    Anesth Analg; 2005 Dec; 101(6):1821-1823. PubMed ID: 16301266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Factor V Leiden mutation and pregnancy complications].
    Abraitis V; Mongirdiene A; Mockeviciene A
    Medicina (Kaunas); 2003; 39(9):823-9. PubMed ID: 14515043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The frequency of venous thromboembolism in women with Leiden mutation in association with pregnancy and puerperium].
    Dulícek P; Malý J; Kalousek I; Beránek M; Pecka M
    Ceska Gynekol; 2005 Mar; 70(2):133-8. PubMed ID: 15918268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rebuttal: Counseling pregnant women with factor V Leiden homozygosity: use absolute instead of relative risks.
    Middeldorp S; van der Meer J; Hamulyák K; Büller HR
    Thromb Haemost; 2002 Feb; 87(2):360-1; author reply 361. PubMed ID: 11858509
    [No Abstract]   [Full Text] [Related]  

  • 12. Factor V Leiden mutation in pregnancy.
    Cohen SM
    J Obstet Gynecol Neonatal Nurs; 2004; 33(3):348-53. PubMed ID: 15180198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic medicine.
    Weed HG; Medow MA
    N Engl J Med; 2003 Feb; 348(8):759-60; author reply 759-60. PubMed ID: 12594326
    [No Abstract]   [Full Text] [Related]  

  • 14. Resistance to activated protein C--frequent etiologic factor for venous thrombosis.
    Simkova M; Simko F; Kovacs L
    Bratisl Lek Listy; 2001; 102(5):240-7. PubMed ID: 11725376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Resistance to activated protein C and pregnancy: thromboprophylaxis with low molecular weight heparin].
    Barjot P; Beucher G; Le Querrec A; Derlon-Borel A; Herlicoviez M
    J Gynecol Obstet Biol Reprod (Paris); 1999 Oct; 28(6):544-9. PubMed ID: 10598348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V Leiden G1691A and factor II G20210A point mutations and pregnancy in North-West of Iran.
    Bagheri M; Rad IA; Nanbakhsh F
    Arch Gynecol Obstet; 2011 Nov; 284(5):1311-5. PubMed ID: 21773779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The factor V Leiden mutation in Japanese couples with recurrent spontaneous abortion.
    Hashimoto K; Shizusawa Y; Shimoya K; Ohashi K; Shimizu T; Azuma C; Murata Y
    Hum Reprod; 1999 Jul; 14(7):1872-4. PubMed ID: 10402408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adrenal vein thrombosis during pregnancy].
    Schmitt C; Debord MP; Grange C; Ben Cheikh A; Krauth JP; Dupuis O; Golfier F; Raudrant D
    J Gynecol Obstet Biol Reprod (Paris); 2010 Feb; 39(1):68-71. PubMed ID: 19896780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstetric implications of the factor V leiden mutation: a review.
    Bloomenthal D; Delisle MF; Tessier F; Tsang P
    Am J Perinatol; 2002 Jan; 19(1):37-47. PubMed ID: 11857095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Leiden and its relevance in patients with recurrent abortions.
    Pauer HU; Neesen J; Hinney B
    Am J Obstet Gynecol; 1998 Mar; 178(3):629. PubMed ID: 9539549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.